Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 27Lymphoma, Non-Hodgkin 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Follicular 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma, Mantle-Cell 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Burkitt Lymphoma 24Sezary Syndrome 23Mycosis Fungoides 22Leukemia, Myeloid, Acute 22Hodgkin Disease 22Multiple Myeloma 21Leukemia, Myeloid, Chronic-Phase 20Congenital Abnormalities 18Leukemia, Myeloid, Accelerated Phase 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Large-Cell, Anaplastic 16Dendritic Cell Sarcoma, Interdigitating 16Recurrence 15Myeloproliferative Disorders 15Lymphoma 15Immunoblastic Lymphadenopathy 15Leukemia, Myelomonocytic, Chronic 14Leukemia 14Waldenstrom Macroglobulinemia 13Lymphoma, Extranodal NK-T-Cell 13Blast Crisis 13

Interventions

denileukin diftitox 2Nivolumab 2sargramostim 1peginterferon alfa-2b 1Prednisone 1Phenobarbital 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Irinotecan 1Introns 1Infliximab 1Etoposide 1Dexamethasone 1Cyclosporine 1Cyclophosphamide 1Cisplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cyclosporine × Dermatologic × Clear all
NCT00002759 2013-02-05

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Neutropenia, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡